Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in acute non-neoplastic portal vein thrombosis and HCV cirrhosis
NCT03201367Completed
- Sponsor
- Zagazig University
- Start
- May 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Open-label trial of rivaroxaban in portal vein thrombosis (PVT) (2 arms), sponsored by Zagazig University. Primary endpoint: Complete recanalization of the portal vein at 6 months. Started May 2014; status: completed.
02
Drugs
rivaroxaban
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT03201367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201367.